E-LIB Suche - Ergebnisse für: Mashiro Okunaka

1

Prognosis of patients with residual pathological disease af..:

Okunaka, Mashiro ; Kotani, Daisuke ; Fujiwara, Hisashi...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

2

Potential Efficacy of Shiunko for Anti-Epidermal Growth Fac..:

Okunaka, Mashiro ; Kotani, Daisuke ; Mishima, Saori...
Integrative Cancer Therapies. 23 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

3

Efficacy and safety of trifluridine/tipiracil plus ramuciru..:

Okunaka, Mashiro ; Kawazoe, Akihito ; Nakamura, Hitomi...
Gastric Cancer. 26 (2023) 6 - p. 1030-1039 , 2023

Link: https://doi.org/10.1007/..

4

Nuclear Receptor and Stress Response Pathways Associated wi..:

Okunaka, Mashiro ; Kano, Daisuke ; Uesawa, Yoshihiro
International Journal of Molecular Sciences. 23 (2022) 20 - p. 12407 , 2022

Link: https://doi.org/10.3390/..

5

Evaluation of the Expression Profile of Irinotecan-Induced ..:

Okunaka, Mashiro ; Kano, Daisuke ; Matsui, Reiko..
Pharmaceuticals. 14 (2021) 4 - p. 377 , 2021

Link: https://doi.org/10.3390/..

6

The efficacy and safety of paclitaxel plus bevacizumab ther..:

Funasaka, Chikako ; Naito, Yoichi ; Kusuhara, Shota...
The Breast. 58 (2021) - p. 50-56 , 2021

Link: https://doi.org/10.1016/..

7

Comprehensive Analysis of Chemotherapeutic Agents That Indu..:

Okunaka, Mashiro ; Kano, Daisuke ; Matsui, Reiko..
Pharmaceuticals. 14 (2021) 7 - p. 681 , 2021

Link: https://doi.org/10.3390/..

8

Significance of chemotherapy-free interval and tumor regres..:

Okunaka, Mashiro ; Kotani, Daisuke ; Demachi, Ken...
Esophagus. 19 (2021) 2 - p. 240-249 , 2021

Link: https://doi.org/10.1007/..

9

Retrospective cohort study of nanoparticle albumin-bound pa..:

Okunaka, Mashiro ; Kotani, Daisuke ; Demachi, Ken...
BMC Cancer. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

10

Improved efficacy of taxanes and ramucirumab combination ch..:

Sasaki, Akinori ; Kawazoe, Akihito ; Eto, Testuya...
ESMO Open. 5 (2020) 4 - p. e000775 , 2020

Link: https://doi.org/10.1136/..

11

sj-pptx-1-ict-10.1177_15347354231225962 – Supplemental mate..:

Mashiro Okunaka ; Daisuke Kotani ; Saori Mishima...
doi:10.25384/sage.25034977.v1. , 2024

Link: https://doi.org/10.25384..

12

sj-docx-1-tam-10.1177_17588359241229432 – Supplemental mate..:

Mashiro Okunaka ; Daisuke Kotani ; Hisashi Fujiwara...
doi:10.25384/sage.25283561.v1. , 2024

Link: https://doi.org/10.25384..

13

sj-pptx-1-ict-10.1177_15347354231225962 – Supplemental mate..:

Mashiro Okunaka ; Daisuke Kotani ; Saori Mishima...
doi:10.25384/sage.25034977.v1. , 2024

Link: https://doi.org/10.25384..

14

sj-docx-1-tam-10.1177_17588359241229432 – Supplemental mate..:

Mashiro Okunaka ; Daisuke Kotani ; Hisashi Fujiwara...
doi:10.25384/sage.25283561.v1. , 2024

Link: https://doi.org/10.25384..

15

Nuclear Receptor and Stress Response Pathways Associated wi..:

Mashiro Okunaka ; Daisuke Kano ; Yoshihiro Uesawa
https://www.mdpi.com/1422-0067/23/20/12407. , 2022

Link: https://doi.org/10.3390/..